(Date:12/15/2009)... time and money with comprehensive solution , ... ... Epocrates, Inc., developer of the most popular medical ... new premium software suite for the platform – Epocrates® ... rely on Epocrates products on their iPhone and iPod touch ...
(Date:12/15/2009)... earn your trust as the most caring, conscientious practice you have ... into the Dermatology Center of Dallas, we can help to achieve ... ... TX (PRWEB) December 15, 2009 -- The Dermatology Center of Dallas, ... the arrival of Jeri Beth “J.B.” Foshee, MD in their practice. ...
(Date:12/15/2009)... Telangiectasia , ... (PRWEB) December 10, 2009 -- Millions of men and ... those unsightly clusters of red, blue or purple veins that spider-web across ... like the US, it’s been estimated that 25-30% of women and 10-20% ... ,Although the Veinwave has been available for over 8 years ...
(Date:12/15/2009)... A study in the Dec. 15 issue ... indicates that significant associations exist between parent-reported ... and headaches in young school-aged children. , ... insomnia was 3.3 times more likely in children ... in children with headaches. Nineteen percent of ...
(Date:12/14/2009)... more… , ... Santa Barbara, California ... scientists at University of Michigan, have developed synthetic particles that ... blood cells, including softness, flexibility, and the ability to carry ... natural red blood cells is to carry oxygen, and the ...
Breaking Medicine News(10 mins):Health News:Epocrates Expands iPhone Offerings with New Premium Content 2Health News:Epocrates Expands iPhone Offerings with New Premium Content 3Health News:Jeri Beth “J.B.” Foshee, MD Joins Dermatology Center of Dallas 2Health News:Vein Center & CosMed, Inc. Selected as Exclusive St. Louis Provider of FDA-Cleared Device 2Health News:Insomnia symptoms linked with medical complaints in young school-aged children 2Health News:Insomnia symptoms linked with medical complaints in young school-aged children 3Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3... Protalix,BioTherapeutics, Inc. (Amex: PLX ), noted today ... (GCD), which is used as,an enzyme replacement therapy ... Most Promising Drugs Entering Phase III Trials in ... report published by Thomson Scientific. Thomson,Scientific, a part ...
... Quality/Patient Safety Initiatives; Geared to Reducing ... Operating Room Efficiencies, LAKE FOREST, Ill., Dec. ... outsourced hospital compounded sterile preparations, is,offering availability of ... reducing medication errors and improving OR,efficiencies. The service ...
... No longer are helmets,enough for motorcyclists to ... Motorcycle Cancer?, author Randall Dale,Chipkar considers motorcycle radiation ... may have a higher risk for cancer development ... says,Chipkar. "Is it a paradox that thousands of ...
... and their ... employees, CHICAGO, Dec. ... care costs and help employees,identify their health risks and cut back on ... smoking cessation,plans and counseling to discounted gym memberships and even acupuncture --,can ...
... Foot Health Can Prevent High Heel Hangover, SALEM, N.H., ... burning you feel after a day or night in heels. ... heel hangover can be,eliminated from your life, without having to ... confessed "shoe addicts" but they don,t think about,how the shoes ...
... 3 SGX Pharmaceuticals, Inc.,(Nasdaq: SGXP ) ... new,drug (IND) application to the U.S. Food and ... developed, orally-bioavailable, small,molecule inhibitor of the cMET receptor ... clinical trials of SGX523 for solid tumor cancer,patients ...
Other Medicine News:Health News:Protalix BioTherapeutics' prGCD Named One of the Five Most Promising Drugs Entering Phase III Trials by Thomson Scientific 2Health News:Protalix BioTherapeutics' prGCD Named One of the Five Most Promising Drugs Entering Phase III Trials by Thomson Scientific 3Health News:PharMEDium Announces Availability of Pre-Filled Operating Room Perioperative Compounded Drugs 2Health News:Motorcycle Radiation May Be Linked to Cancer Risk 2Health News:Employee Health Includes Financial Health, Too 2Health News:High Heel Health 2Health News:SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor 2Health News:SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor 3(Date:12/15/2009)... Medical Systems (NYSE: VAR ) announced today ... fiscal year 2010 following the close of regular trading ... will be followed by a teleconference available to all ... release and a link to the conference call webcast ... www.varian.com/investor . To access the teleconference call and ...
(Date:12/15/2009)... Calif., Dec. 15 Genomic Health, Inc. (Nasdaq: ... studies on its Onco type DX® breast cancer ... to predict the likelihood of chemotherapy benefit and recurrence ... were presented at the 32nd Annual CTRC-AACR San Antonio ... in San Antonio, TX. ,, "The breadth of data ...
(Date:12/15/2009)... /PRNewswire-Asia/ -- Sinovac Biotech Ltd. ( SVA),a ... announced today,that Weidong Yin, Chairman, President & ... to be one of 18 nominees for ... CCTV,s Economic Man-of-the-Year is the country,s ... to as the "Oscar Award of the,Chinese ...
Breaking Medicine Technology:Varian Medical Systems Schedules First Quarter FY2010 News Release and Conference Call 2Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 2Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 3Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 4Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 5Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 6Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 7Sinovac's CEO Weidong Yin Nominated for China Central Television's Prestigious Economic Man-of-the-Year Award 2Sinovac's CEO Weidong Yin Nominated for China Central Television's Prestigious Economic Man-of-the-Year Award 3New AMA Ad Emphasizes Common Ground on Health Reform Shares Vision to Fix Broken System 52955 1New AMA Ad Emphasizes Common Ground on Health Reform Shares Vision to Fix Broken System 52955 2HOWARU 28R 29 Protect Clinically Shown to Reduce the Incidence and Severity of Cold and Flu Symptoms in Children 52951 1HOWARU 28R 29 Protect Clinically Shown to Reduce the Incidence and Severity of Cold and Flu Symptoms in Children 52951 2Clyde C Tuggle Senior Vice President at The Coca Cola Company Elected to CASA Board 52947 1Clyde C Tuggle Senior Vice President at The Coca Cola Company Elected to CASA Board 52947 2Clyde C Tuggle Senior Vice President at The Coca Cola Company Elected to CASA Board 52947 3... March 14 Lung Cancer Alliance,(LCA) called the new ... "a positive step in the right direction,that will encourage ... investigate,their option of getting a CT scan.", LCA ... continue,to kill more people each year than all the ...
... Ortho Biotech is concerned,by the Advisory Committee,s ... for chemotherapy-induced anemia,(CIA) in patients with metastatic ... treated with curative intent. The company believes ... have the choice to use this,important medication, ...
Other Medicine Technology:Lung Cancer Alliance Commends NCCN on Screening Guidelines 2Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote 2Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote 3Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote 4Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote 5Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote 6... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products:Biology NavigationMedical Navigation